Biotech Values

[Regulardoc]

While many patients received DVT prophylaxis of one type or another for years, given the threat of non-reimbursement and additional penalties, most hospitals have either initiated facility-wide education and/or pre-printed orders requiring opt -in/opt-out decisions.

This will drive increase utilization of DVT prophylaxis dosing of enoxaparin.

Related to the other issue, DVT prophylaxis dosing does not require reversal prior to an invasive procedure. At most, you hold the scheduled dose prior to the procedure.